Cargando…

Hyper IgE recurrent infection syndrome in South Asia: is there a different outcome?

BACKGROUND: Hyper IgE recurrent infection syndrome (HIES) is a rare immune deficiency, characterized by recurrent staphylococcal skin and lung abscesses, pneumonia and increased IgE levels. The majority of autosomal dominant HIES (AD HIGE) is due to hypomorphic mutations in the signal transducer and...

Descripción completa

Detalles Bibliográficos
Autores principales: de Silva, Rajiva, Dasanayake, Dhanushka, Senanayake, Manouri, Ediriweera, Ramya, Dias, Savithri, Karunatilleke, Chandima, Brocas, Karen, Tahami, Fariba, Seneviratne, Suranjith
Formato: Online Artículo Texto
Lenguaje:English
Publicado: BioMed Central 2018
Materias:
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC6214173/
https://www.ncbi.nlm.nih.gov/pubmed/30410549
http://dx.doi.org/10.1186/s13223-018-0292-3
_version_ 1783367938649096192
author de Silva, Rajiva
Dasanayake, Dhanushka
Senanayake, Manouri
Ediriweera, Ramya
Dias, Savithri
Karunatilleke, Chandima
Brocas, Karen
Tahami, Fariba
Seneviratne, Suranjith
author_facet de Silva, Rajiva
Dasanayake, Dhanushka
Senanayake, Manouri
Ediriweera, Ramya
Dias, Savithri
Karunatilleke, Chandima
Brocas, Karen
Tahami, Fariba
Seneviratne, Suranjith
author_sort de Silva, Rajiva
collection PubMed
description BACKGROUND: Hyper IgE recurrent infection syndrome (HIES) is a rare immune deficiency, characterized by recurrent staphylococcal skin and lung abscesses, pneumonia and increased IgE levels. The majority of autosomal dominant HIES (AD HIGE) is due to hypomorphic mutations in the signal transducer and the activator of transcription 3 (STAT3) gene. CASE PRESENTATION: Five patients were diagnosed with HIES, based on the clinical criteria and scoring system developed at the National Institutes of Health (NIH), USA. The STAT3 gene was sequenced and previously described mutations were identified in all five patients. We compare the clinical features of our patients with those from Asia, Europe and the US. CONCLUSION: Even though the number of patients is limited, there are some clinical differences in patients from South Asia compared to European and even East Asian patients. However, the mutations detected are located at hot spots seen in western and Asian patients with AD HIGE.
format Online
Article
Text
id pubmed-6214173
institution National Center for Biotechnology Information
language English
publishDate 2018
publisher BioMed Central
record_format MEDLINE/PubMed
spelling pubmed-62141732018-11-08 Hyper IgE recurrent infection syndrome in South Asia: is there a different outcome? de Silva, Rajiva Dasanayake, Dhanushka Senanayake, Manouri Ediriweera, Ramya Dias, Savithri Karunatilleke, Chandima Brocas, Karen Tahami, Fariba Seneviratne, Suranjith Allergy Asthma Clin Immunol Case Report BACKGROUND: Hyper IgE recurrent infection syndrome (HIES) is a rare immune deficiency, characterized by recurrent staphylococcal skin and lung abscesses, pneumonia and increased IgE levels. The majority of autosomal dominant HIES (AD HIGE) is due to hypomorphic mutations in the signal transducer and the activator of transcription 3 (STAT3) gene. CASE PRESENTATION: Five patients were diagnosed with HIES, based on the clinical criteria and scoring system developed at the National Institutes of Health (NIH), USA. The STAT3 gene was sequenced and previously described mutations were identified in all five patients. We compare the clinical features of our patients with those from Asia, Europe and the US. CONCLUSION: Even though the number of patients is limited, there are some clinical differences in patients from South Asia compared to European and even East Asian patients. However, the mutations detected are located at hot spots seen in western and Asian patients with AD HIGE. BioMed Central 2018-11-02 /pmc/articles/PMC6214173/ /pubmed/30410549 http://dx.doi.org/10.1186/s13223-018-0292-3 Text en © The Author(s) 2018 Open AccessThis article is distributed under the terms of the Creative Commons Attribution 4.0 International License (http://creativecommons.org/licenses/by/4.0/), which permits unrestricted use, distribution, and reproduction in any medium, provided you give appropriate credit to the original author(s) and the source, provide a link to the Creative Commons license, and indicate if changes were made. The Creative Commons Public Domain Dedication waiver (http://creativecommons.org/publicdomain/zero/1.0/) applies to the data made available in this article, unless otherwise stated.
spellingShingle Case Report
de Silva, Rajiva
Dasanayake, Dhanushka
Senanayake, Manouri
Ediriweera, Ramya
Dias, Savithri
Karunatilleke, Chandima
Brocas, Karen
Tahami, Fariba
Seneviratne, Suranjith
Hyper IgE recurrent infection syndrome in South Asia: is there a different outcome?
title Hyper IgE recurrent infection syndrome in South Asia: is there a different outcome?
title_full Hyper IgE recurrent infection syndrome in South Asia: is there a different outcome?
title_fullStr Hyper IgE recurrent infection syndrome in South Asia: is there a different outcome?
title_full_unstemmed Hyper IgE recurrent infection syndrome in South Asia: is there a different outcome?
title_short Hyper IgE recurrent infection syndrome in South Asia: is there a different outcome?
title_sort hyper ige recurrent infection syndrome in south asia: is there a different outcome?
topic Case Report
url https://www.ncbi.nlm.nih.gov/pmc/articles/PMC6214173/
https://www.ncbi.nlm.nih.gov/pubmed/30410549
http://dx.doi.org/10.1186/s13223-018-0292-3
work_keys_str_mv AT desilvarajiva hyperigerecurrentinfectionsyndromeinsouthasiaisthereadifferentoutcome
AT dasanayakedhanushka hyperigerecurrentinfectionsyndromeinsouthasiaisthereadifferentoutcome
AT senanayakemanouri hyperigerecurrentinfectionsyndromeinsouthasiaisthereadifferentoutcome
AT ediriweeraramya hyperigerecurrentinfectionsyndromeinsouthasiaisthereadifferentoutcome
AT diassavithri hyperigerecurrentinfectionsyndromeinsouthasiaisthereadifferentoutcome
AT karunatillekechandima hyperigerecurrentinfectionsyndromeinsouthasiaisthereadifferentoutcome
AT brocaskaren hyperigerecurrentinfectionsyndromeinsouthasiaisthereadifferentoutcome
AT tahamifariba hyperigerecurrentinfectionsyndromeinsouthasiaisthereadifferentoutcome
AT seneviratnesuranjith hyperigerecurrentinfectionsyndromeinsouthasiaisthereadifferentoutcome